教授
余睿羚
Email: lingyu@mail.ncku.edu.tw
Representative works
Yu, R. L., Lee, W. J., Li, J. Y., Chang, Y. Y., Chen, C. C., Lin, J. J., Sung, Y. F., Lin, T. K., & Fuh, J. L. (2020). Evaluating Mild Cognitive Dysfunction in Patients with Parkinson’s Disease in Clinical Practice in Taiwan. Scientific reports, 10(1), [1014]. https://doi.org/10.1038/s41598-020-58042-2
Lin, C. Y., Yu, R. L., Wu, R. M., & Tan, C. H. (2019). Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson’s Disease. Scientific reports, 9(1), [18950]. https://doi.org/10.1038/s41598-019-55427-w
Fang, Y. J., Tan, C. H., Tu, S. C., Liu, C. Y., & Yu, R. L. (2019). More than an “inverted-U”? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson’s disease. PloS one, 14(3), [e0214146]. https://doi.org/10.1371/journal.pone.0214146
Chih Liu, P., Chen, P. S., Lu, R. B., Hsiang Tan, C., Ching Tu, S., & Ling Yu, R. (2018). Effect of Aldehyde Dehydrogenase 2 Gene Polymorphism on Executive Function in Opiate User. Neuropsychiatry, 08(03). https://doi.org/10.4172/Neuropsychiatry.1000427
Yu, R., Chen, P. S., Tu, S., Tsao, W., & Tan, C. (2018). Emotion-Specific Affective Theory of Mind Impairment in Parkinson’s Disease. Scientific Reports, 8(1). https://doi.org/10.1038/s41598-018-33988-6
Yu, R., Wu, R., Chan, A. Y. Y., Mok, V., Wu, Y., Tilley, B. C., Luo, S., Wang, L., Lapelle, N. R., Stebbins, G. T., & Goetz, C. G. (2017). Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Movement Disorders Clinical Practice, 4(1), 68-77. https://doi.org/10.1002/mdc3.12349
Yu, R. L., Wu, R. M., Chan, A. Y. Y., Mok, V., Wu, Y. R., Tilley, B. C., Luo, S., Wang, L., LaPelle, N. R., Stebbins, G. T., & Goetz, C. G. (2017). Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale. Movement Disorders Clinical Practice, 4(1), 68-77. https://doi.org/10.1002/mdc3.12349
Yu, R. L., Tan, C. H., Lu, Y. C., & Wu, R. M. (2016). Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson's disease. Scientific reports, 6, [30424]. https://doi.org/10.1038/srep30424
Yu, R. L., Tan, C. H., Wu, Y. R., Wu, R. M., Chiu, M. J., & Hua, M. S. (2015). Memory for gist and detail information in patients with Parkinson's disease. BMJ open, 5(11), e009795. https://doi.org/10.1136/bmjopen-2015-009795
Yu, R. L., Tan, C. H., & Wu, R. M. (2015). The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease. Neuropsychiatric Disease and Treatment, 11, 2005-2012. https://doi.org/10.2147/NDT.S85483
Liu, W. M., Lin, R. J., Yu, R. L., Tai, C. H., Lin, C. H., & Wu, R. M. (2015). The impact of nonmotor symptoms on quality of life in patients with parkinson’s disease in Taiwan. Neuropsychiatric Disease and Treatment, 11, 2865-2873. https://doi.org/10.2147/NDT.S88968
Representative works
Yu, R. L., Lee, W. J., Li, J. Y., Chang, Y. Y., Chen, C. C., Lin, J. J., Sung, Y. F., Lin, T. K., & Fuh, J. L. (2020). Evaluating Mild Cognitive Dysfunction in Patients with Parkinson’s Disease in Clinical Practice in Taiwan. Scientific reports, 10(1), [1014]. https://doi.org/10.1038/s41598-020-58042-2
Lin, C. Y., Yu, R. L., Wu, R. M., & Tan, C. H. (2019). Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson’s Disease. Scientific reports, 9(1), [18950]. https://doi.org/10.1038/s41598-019-55427-w
Fang, Y. J., Tan, C. H., Tu, S. C., Liu, C. Y., & Yu, R. L. (2019). More than an “inverted-U”? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson’s disease. PloS one, 14(3), [e0214146]. https://doi.org/10.1371/journal.pone.0214146
Chih Liu, P., Chen, P. S., Lu, R. B., Hsiang Tan, C., Ching Tu, S., & Ling Yu, R. (2018). Effect of Aldehyde Dehydrogenase 2 Gene Polymorphism on Executive Function in Opiate User. Neuropsychiatry, 08(03). https://doi.org/10.4172/Neuropsychiatry.1000427
Yu, R., Chen, P. S., Tu, S., Tsao, W., & Tan, C. (2018). Emotion-Specific Affective Theory of Mind Impairment in Parkinson’s Disease. Scientific Reports, 8(1). https://doi.org/10.1038/s41598-018-33988-6
Yu, R., Wu, R., Chan, A. Y. Y., Mok, V., Wu, Y., Tilley, B. C., Luo, S., Wang, L., Lapelle, N. R., Stebbins, G. T., & Goetz, C. G. (2017). Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Movement Disorders Clinical Practice, 4(1), 68-77. https://doi.org/10.1002/mdc3.12349
Yu, R. L., Wu, R. M., Chan, A. Y. Y., Mok, V., Wu, Y. R., Tilley, B. C., Luo, S., Wang, L., LaPelle, N. R., Stebbins, G. T., & Goetz, C. G. (2017). Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale. Movement Disorders Clinical Practice, 4(1), 68-77. https://doi.org/10.1002/mdc3.12349
Yu, R. L., Tan, C. H., Lu, Y. C., & Wu, R. M. (2016). Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson's disease. Scientific reports, 6, [30424]. https://doi.org/10.1038/srep30424
Yu, R. L., Tan, C. H., Wu, Y. R., Wu, R. M., Chiu, M. J., & Hua, M. S. (2015). Memory for gist and detail information in patients with Parkinson's disease. BMJ open, 5(11), e009795. https://doi.org/10.1136/bmjopen-2015-009795
Yu, R. L., Tan, C. H., & Wu, R. M. (2015). The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease. Neuropsychiatric Disease and Treatment, 11, 2005-2012. https://doi.org/10.2147/NDT.S85483
Liu, W. M., Lin, R. J., Yu, R. L., Tai, C. H., Lin, C. H., & Wu, R. M. (2015). The impact of nonmotor symptoms on quality of life in patients with parkinson’s disease in Taiwan. Neuropsychiatric Disease and Treatment, 11, 2865-2873. https://doi.org/10.2147/NDT.S88968